Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMI-DC in Acute Anterior Wall STEMI
NCT05554484Phase 2Unknown
- Sponsor
- The Catholic University of Korea
- Start
- Jun 2021
- Primary completion
- Jul 2023
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of AMI-DC in myocardial infarction (MI), sponsored by The Catholic University of Korea. Status: unknown.
02
Drugs
AMI-DC
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT05554484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05554484.